Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key (Nasdaq: BKYI) announced that the Central Bank of Jordan (CBJ) has selected the company for a national biometric authentication initiative across Jordan’s financial sector, which serves about 11.6 million people. The project aims to shift end-client authentication toward a biometric-first model, reducing reliance on passwords, tokens and other legacy methods.
The CBJ is using BIO-key’s PortalGuard and WEB-key technologies to enable secure biometric authentication across digital and financial environments. BIO-key’s past contribution to a biometric banking deployment serving over 30 million customers and 850+ branches was highlighted. The scope, implementation framework and timeline for the Jordan initiative are still being developed between CBJ and BIO-key.
BIO-key (Nasdaq: BKYI) announced that trading of its common stock will resume on the Nasdaq Capital Market at the market open on Wednesday, July 8, 2026. A Nasdaq Hearings Panel determined the company has regained compliance with continued listing standards, including minimum bid price and SEC filing requirements. BIO-key will be under a Discretionary Panel Monitor until July 6, 2027. Management highlights a growing base of recurring revenue, expanding interest in its biometric cybersecurity solutions, a solid financial position, and a streamlined cost structure, and expects significantly improved business results in 2026.
BIO-key (OTCQB: BKYI) will showcase its biometric-powered, passwordless identity and access management solutions at an invitation-only banking cybersecurity workshop in Amman, Jordan, on July 6. The Association of Banks in Jordan is hosting over 25 financial institutions, including C-level executives.
Sessions highlight BIO-key’s Identity-Bound Biometrics and PortalGuard IAM for secure, frictionless authentication, improved user experience, operational efficiency, regulatory compliance support, and cyber threat mitigation for regional banks undergoing digital transformation.
BIO-key (OTC:BKYI) CEO Michael DePasquale will join a webcast fireside chat at Maxim Group’s Defense Tech Virtual Conference on Thursday, June 25, 2026 at 4:00 p.m. ET (Track 2). Investors can register online to attend the virtual event.
DePasquale plans to discuss BIO-key’s biometric authentication solutions for military, defense and other high-value sectors, and provide an outlook including anticipated 50% 1H 2026 revenue growth to about $5M and a shift to profitability compared with a $(1.9M) loss in 1H 2025.
BIO-key (OTC Markets: BKYI) received a Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) because it did not timely file its Form 10-Q for the quarter ended March 31, 2026.
A Nasdaq Hearing Panel will consider this issue when deciding BIO-key’s continued listing on the Nasdaq Capital Market.
BIO-key (OTC:BKYI) will present at the RedChip Future Tech Investor Conference on Wednesday, June 10, 2026 at 3:00 pm ET, followed by a live Q&A.
The company expects 1H 2026 revenue of about $5M, up from $3.3M, and to reach 1H profitability.
BIO-key (OTC:BKYI) announced a strategic partnership with IT solutions provider BlueAlly, highlighted by deployment of its PortalGuard platform at AOD Federal Credit Union in Alabama.
The rollout delivers phishing-resistant, identity-bound biometric authentication to reduce MFA-related risks, streamline operations, lower help desk demand, and support zero-trust security and regulatory compliance.
BIO-key (OTC:BKYI) formed a strategic partnership with BlueAlly to deliver phishing-resistant biometric authentication, debuting with a deployment at AOD Federal Credit Union in Alabama.
AOD, serving over 37,500 members across seven branches, uses BIO-key’s PortalGuard and Identity-Bound Biometrics to reduce credential-based risks, streamline passwords, support zero-trust, and ease IT workloads.
BIO-key (OTC: BKYI) reported Q1 2026 revenue of $2.15M, up about 34% year over year, with an 82% gross margin. Net loss narrowed to $165K. The company expects Q2 revenue of roughly $2.8M (about 65% above prior-year Q2) and 1H 2026 revenue of about $5M, up 50%, with anticipated first-half profitability and cash roughly in line with current levels. Current cash is $2.2M and stockholders’ equity is $7.43M. BIO-key highlighted finance, defense and government wins, but noted its shares were suspended from Nasdaq and now trade on OTC Markets as BKYI while it seeks relisting.
BIO-key (Nasdaq: BKYI) will have its common stock trading suspended from Nasdaq after the May 12, 2026 close and expects quotation on OTC Markets under BKYI starting May 13. The suspension reflects bid-price non-compliance and a delayed 2025 Form 10-K filing.
The company plans to seek a Nasdaq hearing and targets 1H 2026 revenue of $5M (up from $3.3M in 1H 2025) and profitability.